HIV-1, the causative agent of acquired immunodeficiency syndrome (AIDS), contains an RNA genome that produces a chromosomally integrated DNA during the replicative cycle. Activation of HIV-1 gene expression by the transactivator Tat is dependent on an RNA regulatory element (TAR) located downstream of the transcription initiation site. The protein encoded by this gene binds between the bulge and the loop of the HIV-1 TAR RNA regulatory element and activates HIV-1 gene expression in synergy with the viral Tat protein. Alternative splicing results in multiple transcript variants encoding different isoforms. This gene also has a pseudogene.[2]
↑Gatignol A, Buckler-White A, Berkhout B, Jeang KT (Mar 1991). "Characterization of a human TAR RNA-binding protein that activates the HIV-1 LTR". Science. 251 (5001): 1597–600. doi:10.1126/science.2011739. PMID2011739.
↑Daher A, Longuet M, Dorin D, Bois F, Segeral E, Bannwarth S, Battisti PL, Purcell DF, Benarous R, Vaquero C, Meurs EF, Gatignol A (Sep 2001). "Two dimerization domains in the trans-activation response RNA-binding protein (TRBP) individually reverse the protein kinase R inhibition of HIV-1 long terminal repeat expression". The Journal of Biological Chemistry. 276 (36): 33899–905. doi:10.1074/jbc.M103584200. PMID11438532.
↑Iwasaki T, Chin WW, Ko L (Sep 2001). "Identification and characterization of RRM-containing coactivator activator (CoAA) as TRBP-interacting protein, and its splice variant as a coactivator modulator (CoAM)". The Journal of Biological Chemistry. 276 (36): 33375–83. doi:10.1074/jbc.M101517200. PMID11443112.
Kozak CA, Gatignol A, Graham K, Jeang KT, McBride OW (Jan 1995). "Genetic mapping in human and mouse of the locus encoding TRBP, a protein that binds the TAR region of the human immunodeficiency virus (HIV-1)". Genomics. 25 (1): 66–72. doi:10.1016/0888-7543(95)80110-8. PMID7774957.
Gatignol A, Duarte M, Daviet L, Chang YN, Jeang KT (1996). "Sequential steps in Tat trans-activation of HIV-1 mediated through cellular DNA, RNA, and protein binding factors". Gene Expression. 5 (4–5): 217–28. PMID8723388.
Daviet L, Erard M, Dorin D, Duarte M, Vaquero C, Gatignol A (Apr 2000). "Analysis of a binding difference between the two dsRNA-binding domains in TRBP reveals the modular function of a KR-helix motif". European Journal of Biochemistry / FEBS. 267 (8): 2419–31. doi:10.1046/j.1432-1327.2000.01256.x. PMID10759868.
Duarte M, Graham K, Daher A, Battisti PL, Bannwarth S, Segeral E, Jeang KT, Gatignol A (2001). "Characterization of TRBP1 and TRBP2. Stable stem-loop structure at the 5' end of TRBP2 mRNA resembles HIV-1 TAR and is not found in its processed pseudogene". Journal of Biomedical Science. 7 (6): 494–506. doi:10.1007/bf02253365. PMID11060498.
Siffroi JP, Pawlak A, Alfonsi MF, Troalen F, Guellaen G, Dadoune JP (Mar 2001). "Expression of the TAR RNA binding protein in human testis". Molecular Human Reproduction. 7 (3): 219–25. doi:10.1093/molehr/7.3.219. PMID11228241.
Daher A, Longuet M, Dorin D, Bois F, Segeral E, Bannwarth S, Battisti PL, Purcell DF, Benarous R, Vaquero C, Meurs EF, Gatignol A (Sep 2001). "Two dimerization domains in the trans-activation response RNA-binding protein (TRBP) individually reverse the protein kinase R inhibition of HIV-1 long terminal repeat expression". The Journal of Biological Chemistry. 276 (36): 33899–905. doi:10.1074/jbc.M103584200. PMID11438532.
Iwasaki T, Chin WW, Ko L (Sep 2001). "Identification and characterization of RRM-containing coactivator activator (CoAA) as TRBP-interacting protein, and its splice variant as a coactivator modulator (CoAM)". The Journal of Biological Chemistry. 276 (36): 33375–83. doi:10.1074/jbc.M101517200. PMID11443112.
Bannwarth S, Talakoub L, Letourneur F, Duarte M, Purcell DF, Hiscott J, Gatignol A (Dec 2001). "Organization of the human tarbp2 gene reveals two promoters that are repressed in an astrocytic cell line". The Journal of Biological Chemistry. 276 (52): 48803–13. doi:10.1074/jbc.M104645200. PMID11641396.
Xu YC, Wu RF, Gu Y, Yang YS, Yang MC, Nwariaku FE, Terada LS (Aug 2002). "Involvement of TRAF4 in oxidative activation of c-Jun N-terminal kinase". The Journal of Biological Chemistry. 277 (31): 28051–7. doi:10.1074/jbc.M202665200. PMID12023963.
Battisti PL, Daher A, Bannwarth S, Voortman J, Peden KW, Hiscott J, Mouland AJ, Benarous R, Gatignol A (Sep 2003). "Additive activity between the trans-activation response RNA-binding protein, TRBP2, and cyclin T1 on HIV type 1 expression and viral production in murine cells". AIDS Research and Human Retroviruses. 19 (9): 767–78. doi:10.1089/088922203769232566. PMID14585207.
Lee JY, Kim H, Ryu CH, Kim JY, Choi BH, Lim Y, Huh PW, Kim YH, Lee KH, Jun TY, Rha HK, Kang JK, Choi CR (Jul 2004). "Merlin, a tumor suppressor, interacts with transactivation-responsive RNA-binding protein and inhibits its oncogenic activity". The Journal of Biological Chemistry. 279 (29): 30265–73. doi:10.1074/jbc.M312083200. PMID15123692.
Rual JF, Venkatesan K, Hao T, Hirozane-Kishikawa T, Dricot A, Li N, Berriz GF, Gibbons FD, Dreze M, Ayivi-Guedehoussou N, Klitgord N, Simon C, Boxem M, Milstein S, Rosenberg J, Goldberg DS, Zhang LV, Wong SL, Franklin G, Li S, Albala JS, Lim J, Fraughton C, Llamosas E, Cevik S, Bex C, Lamesch P, Sikorski RS, Vandenhaute J, Zoghbi HY, Smolyar A, Bosak S, Sequerra R, Doucette-Stamm L, Cusick ME, Hill DE, Roth FP, Vidal M (Oct 2005). "Towards a proteome-scale map of the human protein-protein interaction network". Nature. 437 (7062): 1173–8. doi:10.1038/nature04209. PMID16189514.
Bannwarth S, Lainé S, Daher A, Grandvaux N, Clerzius G, Leblanc AC, Hiscott J, Gatignol A (Feb 2006). "Cell-specific regulation of TRBP1 promoter by NF-Y transcription factor in lymphocytes and astrocytes". Journal of Molecular Biology. 355 (5): 898–910. doi:10.1016/j.jmb.2005.11.026. PMID16343534.